Allen's Pharmacy Cape Ann v. Ferguson

16 Mass. L. Rptr. 336
CourtMassachusetts Superior Court
DecidedJune 2, 2003
DocketNo. 031913BLS
StatusPublished
Cited by1 cases

This text of 16 Mass. L. Rptr. 336 (Allen's Pharmacy Cape Ann v. Ferguson) is published on Counsel Stack Legal Research, covering Massachusetts Superior Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Allen's Pharmacy Cape Ann v. Ferguson, 16 Mass. L. Rptr. 336 (Mass. Ct. App. 2003).

Opinion

van Gestel, J.

Pursuant to a memorandum and order dated May 1, 2003, this Court denied and deferred the plaintiffs’ request for preliminary injunc-tive relief and set the matter down for trial on the merits and a hearing on injunctive relief for May 12, 2003. At the request of the parties, the trial was continued to May 21, 2003. What follows are this Court’s findings of fact, rulings of law and an order for judgment.

The case came before the Court in essence as a “case stated.” The parties have agreed that the facts involved are those in the affidavits filed by the plaintiffs and the defendant and those exhibits included as parts of the First Amended Complaint. The defendant challenges certain of the affidavits on relevancy grounds, but accepts them as otherwise accurate.

FINDINGS OF FACT

This matter involves G.L.c. 118G, Sec. 26, a statute adopted as an outside section4 on the legislation for the Massachusetts budget for fiscal year 2003. See Acts of 2002, c. 184, Sec. 101. G.L.c. 118G, Sec. 26, in material part, reads as follows:

(a) For the purposes of this section, the following terms shall have the following meanings:
“Assessment,” for all pharmacies, an amount assessed upon each non-Medicare and non-Medicaid prescription dispensed by the pharmacies.
“Pharmacy.” Any retail drug business registered by the board of registration in pharmacy in accordance with chapter 112 that is authorized to dispense controlled substances, including, retail drug businesses as defined in Section 1 of chapter 94C.
(b) Each pharmacy shall pay an assessment upon each non-Medicare and non-medicaid [sic] prescription dispensed to the division quarterly.5 The assessment shall be sufficient in the aggregate to generate $36 million in each fiscal year. The assessment shall be implemented as a broad-based health-care fee as defined in 42 U.S.C. Sec. 1396b(w)(3)(B). The division may promulgate regulations that authorize the assessment of interest on any unpaid liability at a rate not to exceed an annual percentage rate of 18 per cent and late fees at a rate not to exceed 5 per cent per month. The receipts from the assessment, any federal financial participation received by the commonwealth as a result of expenditures funded by these assessments and interest thereon shall be credited to the Health Care Security Trust Fund established by Section 29D.

Additionally included in the outside section to the 2003 budget bill as a separate section, but not codified in the General Laws, is c. 184, Sec. 186, which reads in part:

(b) Except as provided in subsection (d), the assessments established by Section 26 of chapter 118G shall not be collected and the expenditures required by clause (11) of paragraph (a) of Section 180 shall not be authorized until the division of medical assistance certifies that it has obtained federal approval of any related state plan amendments and of the availability of federal financial participation for MassHealth6 expenditures funded in part or in whole by revenues collected from said assessments.

The Division of Health Care Finance and Policy (“DHCFP”) adopted certain regulations intended to implement the pharmacy assessment. Those regulations became effective on January 1, 2003. See 114.5 CMR secs. 13.01-13.05. Included therein, in Sec. 13.02, is the following definition:

Pharmacy. Any retail drug business registered by the board of registration in pharmacy in accordance with chapter 112 that is authorized to dispense controlled substances, including retail drug businesses as defined in Section 1 of chapter 94C, including retail store pharmacies, long-term care retail pharmacies, community health center pharmacies, hospital outpatient pharmacies and university/college infirmary pharmacies. The term pharmacy does not include hospital inpatient pharmacies.

On November 14, 2002, the Division of Medical Assistance (“DMA”) wrote to the Center for Medicaid and State Operations, known as the Center for Medicaid Services (“CMS”), seeking its assistance “in confirming the availability of federal financial participation (“FFP”) for certain Medicaid expenditures that will be funded by provider assessments newly established under state law (G.L.c. 118G, Sec. 26).”

In the letter to CMS, DMA stated that DHCFP “proposes to comprehensively define the term ‘pharmacy’ in its regulations” in the manner set forth above in 114.5 CMR Sec. 13.02.

On December 23, 2002, CMS responded. It said, among other things: “While we do not offer advisory opinions on State legislation, after review of the information provided in your November 14 request, it appears that Massachusetts’ tax on all non-Medicare, non-Medicaid prescriptions in the state would not trigger penalties under Section 1903(w)(3)(D) of the Social Security Act (the ’’Act”)."

Particularly, the CMS letter went on to say:

Based on the information provided in your letter, it appears that all pharmacies in the State [sic] of Massachusetts will pay a uniform tax on all non-Medicare, non-Medicaid prescriptions dispensed. Thus, the tax appears to be applied in a broad-based and uniform manner consistent with Sections 1903(w)(3)(B) and (C) of the Act.

On December 27, 2002 the DMA “certified” to the Commissioner of DHCFP that it had received the requisite Federal approval from CMS, and enclosed as [338]*338proof a copy of its November 14, 2002 letter and CMS’s reply of December 23, 2002.

On March 14, 2003 CMS responded to an inquiiy from the National Association of Chain Drug Stores. The inquiiy related to the new Massachusetts law and, evidently, suggested that it was not “broad-based” because outpatient hospital pharmacies were not included for the reason that they are not licensed by the State Board of Registry in Pharmacy. The CMS responded, saying: “This broader application of the tax beyond those entities licensed by the State Board was accomplished through regulation in order to ensure that the tax was broad-based and applied uniformly.”

It is in this posture that the plaintiffs have challenged G.L.c. 118G, Sec. 26.

RULINGS OF LAW

What is presented to the Court is an array of legislation, and actions taken purporting to comply therewith, that must be interpreted, construed and applied. As recently as May 8, 2003 the Supreme Judicial Court restated and reaffirmed long-held principles of statutory construction. In Commonwealth v. Clerk-Magistrate of the West Roxbury Div. of the Dist. Court Dep’t, 439 Mass. 352, 355-56 (2003), the SJC said:

It is a standard canon of statutoiy construction that “the primary source of insight into the intent of the Legislature is the language of the statute.” International Fid. Ins. Co. v. Wilson, 387 Mass. 841, 853 (1983). A court may not add words to a statute that the Legislature did not put there. See General Elec. Co. v. Department of Envtl. Protection, 429 Mass. 798, 803 (1999), and cases cited. “Statutoiy language should be given effect consistent with its plain meaning and in light of the aim of the Legislature unless to do so would achieve an illogical result.” Sullivan v. Brookline, 435 Mass. 353, 360 (2001). See O’Brien v. Massachusetts Bay Transp. Auth., 405 Mass. 439, 443-44 (1989).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Long Term Care Pharmacy Alliance v. Ferguson
17 Mass. L. Rptr. 372 (Massachusetts Superior Court, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
16 Mass. L. Rptr. 336, Counsel Stack Legal Research, https://law.counselstack.com/opinion/allens-pharmacy-cape-ann-v-ferguson-masssuperct-2003.